Additionally, HER2-positive breast cancer and TNBC are considered to show more aggressive clinical characteristics and poorer prognosis, resulting in a higher recurrence rate and mortality than luminal-like breast cancer12,13. Here, ERBB2 is linked to breast carcinoma.